Synapse - Works

Results (5914)

Pulsatile administration of the EGF receptor inhibitor Iressa (ZD1839) is significantly more effective than continuous dosing for sensitizing tumors to taxol

Meeting Abstract

Solit, D. B.; She, Y.; Moasser, M. M.; Hudis, C. A.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
Proceedings of the American Association for Cancer Research Annual Meeting (2003)

Fulltext@MSK | Save

ID deficiency cooperates with ansamycins to inhibit the growth of breast tumors that develop spontaneously in MMTV-neu transgenic mice

Meeting Abstract

Solit, D. B.; De Candia, P.; Rosen, N.; Benezra, R.
Proceedings of the American Association for Cancer Research Annual Meeting (2003)

Fulltext@MSK | Save

Response and resistance to gefitinib (ZD1839, Iressa) in HER overexpressing tumor cells is mediated through the PI3K/Akt pathway

Meeting Abstract

She, Q. B.; Solit, D.; Basso, A.; Rosen, N.; Moasser, M. M.
Proceedings of the American Association for Cancer Research Annual Meeting (2003)

Fulltext@MSK | Save

Phase I trial to evaluate J591 as a vascular targeting agent in patients with advanced solid tumors

Meeting Abstract

Morris, M. J.; Divgi, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Shaffer, D.; Halpern, J.; Delacruz, A.; Curley, T.; Nacca, A.; more...
Proceedings of the American Association for Cancer Research Annual Meeting (2003)

Fulltext@MSK | Save

The methylthioadenosine phosphorylase (MTAP) gene is homozygously co-deleted with CDKN2A in most mesotheliomas: Detection by fluorescent in situ hybridization (FISH) and by immunohistochemistry (IHC) using a novel MTAP monoclonal antibody

Meeting Abstract

Illei, P. B.; Leoni, L.; Huang, W.; Astrow, S.; Cheeks, A.; Rusch, V. W.; Ladanyi, M.
Proceedings of the American Association for Cancer Research Annual Meeting (2003)

Fulltext@MSK | Save

Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol

Meeting Abstract

Solit, D. B.; She, Y.; Moasser, M.; Hudis, C.; Kris, M.; Scher, H.; Rosen, N.; Sirotnak, F. M.
Clinical Cancer Research (2003)

Fulltext@MSK | Save

Rapid MicroPET imaging of 17AAG induced HER2 protein downregulation using Ga-68-DOTA-F(ab ')(2) herceptin

Meeting Abstract

Smith-Jones, P. M.; Solit, D.; Afroze, F.; Akhurst, T.; Rosen, N.; Larson, S. M.
Journal of Nuclear Medicine (2003)

Fulltext@MSK | Save

Cyclin D expression and G1 progression are dependent on MEK-MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras

Meeting Abstract

Sawai, A.; Basso, A. D.; Solit, D. B.; She, Q. B.; Grbovic, O.; Pratilas, C.; Chapman, P.; Moasser, M. M.; Rosen, N.
Clinical Cancer Research (2003)

Fulltext@MSK | Save

SV40 infection and p16/CDKN2A deletion as alternative mechanisms of p53 and RB pathway co-inactivation in a series of 65 mesotheliomas

Meeting Abstract

Lopez-Rios, F.; Illei, P. B.; Zhao, Z.; Rusch, V.; Zakowski, M. F.; Ladanyi, M.
Modern Pathology (2003)

Fulltext@MSK | Save

SV40 infection and p16/CDKN2A deletion as alternative mechanisms of p53 and RB pathway co-inactivation in a series of 65 mesotheliomas

Meeting Abstract

Lopez-Rios, F.; Illei, P. B.; Zhao, Z.; Rusch, V.; Zakowski, M. F.; Ladanyi, M.
Laboratory Investigation (2003)

Fulltext@MSK | Save